119 related articles for article (PubMed ID: 28110206)
1. An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome.
Hosoi H; Imadome KI; Tamura S; Kuriyama K; Murata S; Yamashita Y; Mushino T; Oiwa T; Kobata H; Nishikawa A; Nakakuma H; Hanaoka N; Isobe Y; Ohshima K; Sonoki T
Leuk Res; 2017 Apr; 55():1-5. PubMed ID: 28110206
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous involvement by angioimmunoblastic T-cell lymphoma with remarkable heterogeneous Epstein-Barr virus expression.
Brown HA; Macon WR; Kurtin PJ; Gibson LE
J Cutan Pathol; 2001 Sep; 28(8):432-8. PubMed ID: 11493382
[TBL] [Abstract][Full Text] [Related]
3. Composite Epstein-Barr Virus-associated T-lymphoblastic and Peripheral T-cell Lymphomas: A Clonal Study.
Hosoi H; Mushino T; Nakashima K; Kuriyama K; Tamura S; Murata S; Imadome KI; Ohshima K; Sonoki T
Intern Med; 2021 Jul; 60(13):2119-2123. PubMed ID: 33551410
[TBL] [Abstract][Full Text] [Related]
4. CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.
Smith NA; Coleman CB; Gewurz BE; Rochford R
J Virol; 2020 May; 94(11):. PubMed ID: 32238579
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases.
Kato S; Asano N; Miyata-Takata T; Takata K; Elsayed AA; Satou A; Takahashi E; Kinoshita T; Nakamura S
Am J Surg Pathol; 2015 Apr; 39(4):462-71. PubMed ID: 25634749
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus latent infection genes and oncogenes in lymphoma cell lines derived from pyothorax-associated lymphoma.
Kanno H; Yasunaga Y; Ohsawa M; Taniwaki M; Iuchi K; Naka N; Torikai K; Shimoyama M; Aozasa K
Int J Cancer; 1996 Jul; 67(1):86-94. PubMed ID: 8690530
[TBL] [Abstract][Full Text] [Related]
7. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.
Langer R; Geissinger E; Rüdiger T; von Schilling C; Ott G; Mandl-Weber S; Quintanilla-Martinez L; Fend F
Am J Surg Pathol; 2010 Sep; 34(9):1382-7. PubMed ID: 20739840
[TBL] [Abstract][Full Text] [Related]
8. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL.
Paterson RL; Kelleher C; Amankonah TD; Streib JE; Xu JW; Jones JF; Gelfand EW
Blood; 1995 Jan; 85(2):456-64. PubMed ID: 7811999
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T-cell lymphoma complicated by a proliferation of large B cells.
Higgins JP; van de Rijn M; Jones CD; Zehnder JL; Warnke RA
Am J Clin Pathol; 2000 Aug; 114(2):236-47. PubMed ID: 10941339
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia.
Asada H; Okada N; Hashimoto K; Yamanishi K; Sairenji T; Hirota S; Nomura S; Kitamura Y; Yoshikawa K
Leukemia; 1994 Aug; 8(8):1415-23. PubMed ID: 8057683
[TBL] [Abstract][Full Text] [Related]
11. Activation of human thymocytes after infection by EBV.
Paterson RL; Kelleher CA; Streib JE; Amankonah TD; Xu JW; Jones JF; Gelfand EW
J Immunol; 1995 Feb; 154(3):1440-9. PubMed ID: 7822809
[TBL] [Abstract][Full Text] [Related]
12. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
13. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
Endo R; Yoshioka M; Ebihara T; Ishiguro N; Kikuta H; Kobayashi K
Med Hypotheses; 2004; 63(4):582-7. PubMed ID: 15325000
[TBL] [Abstract][Full Text] [Related]
14. Frequent detection of Epstein-Barr virus-infected B cells in peripheral T-cell lymphomas.
Ho JW; Ho FC; Chan AC; Liang RH; Srivastava G
J Pathol; 1998 May; 185(1):79-85. PubMed ID: 9713363
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and CD21 expression in gastrointestinal tumors.
Kim YS; Paik SR; Kim HK; Yeom BW; Kim I; Lee D
Pathol Res Pract; 1998; 194(10):705-11. PubMed ID: 9820867
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
[TBL] [Abstract][Full Text] [Related]
17. Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis.
Larcher C; Fend F; Mitterer M; Prang N; Schwarzmann F; Huemer HP
Br J Haematol; 1995 Jul; 90(3):532-40. PubMed ID: 7646990
[TBL] [Abstract][Full Text] [Related]
18. Characterization of naturally Epstein-Barr virus-infected gastric carcinoma cell line YCCEL1.
Kim DN; Seo MK; Choi H; Kim SY; Shin HJ; Yoon AR; Tao Q; Rha SY; Lee SK
J Gen Virol; 2013 Mar; 94(Pt 3):497-506. PubMed ID: 23175241
[TBL] [Abstract][Full Text] [Related]
19. CD21-independent Epstein-Barr virus entry into NK cells.
Lee JH; Choi J; Ahn YO; Kim TM; Heo DS
Cell Immunol; 2018 May; 327():21-25. PubMed ID: 29499908
[TBL] [Abstract][Full Text] [Related]
20. T- and B-cell clonality and frequency of human herpes viruses-6, -8 and Epstein Barr virus in angioimmunoblastic T-cell lymphoma.
Vrsalovic MM; Korac P; Dominis M; Ostojic S; Mannhalter C; Kusec R
Hematol Oncol; 2004 Dec; 22(4):169-77. PubMed ID: 16134192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
